Biotech · Private company
Capsida Biotherapeutics, Inc.
Track this companyFree. Adds Capsida Biotherapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- gene therapyPhase 2 · Developmental and Epileptic EncephalopathyClinicalTrials.gov · fetched Nov 12, 2026
- gene therapyPhase 2 · GBA1 Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's DiseasePHASE1_PHASE2 · WITHDRAWN · started Aug 18, 2025ClinicalTrials.gov NCT07011771 · fetched Nov 12, 2026
- A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) EncephalopathyPHASE1_PHASE2 · TERMINATED · started Jul 3, 2025ClinicalTrials.gov NCT06983158 · fetched Nov 12, 2026